Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 206 participants.
Also called NCT01230034
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 206 participants
- Sponsor
- Registry
-
NCT01230034 -
2010-023332-17
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01230034. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2011-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria
- Condition
- Hypertension
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Microalbuminuria
- Intervention (Drug)
- Ramipril
- Intervention (Drug)
- Imidapril
- Lead sponsor
- University of Pavia
Record details
- Record id
cardio:ct-nct01230034- Content hash
119c3801bc76e6d44405e7ce475b36d27fd41890b735d12eb8d844edcf899bd6